Management of ankylosing spondylitis
作者： Joachim Sieper , Jürgen Braun
DOI: 10.1007/978-0-85729-180-6_6
关键词: Enthesitis 、 Dermatology 、 Tumor necrosis factor alpha 、 Rheumatism 、 Sulfasalazine 、 Disease 、 Medicine 、 Treatment options 、 Ankylosing spondylitis 、 Arthritis
摘要: Recently, the Assessment of SpondyloArthritis international Society (ASAS) and European League Against Rheumatism (EULAR) recommendations on management AS have been published, based a thorough analysis available literature meeting spondyloarthritides (SpA) experts. These are shown in Figures 6.1 6.2 [54]. Non–drug approaches part therapy at all stages disease. For predominantly axial manifestation, treatment options limited to non–steroidal anti–inflammatory drugs (NSAIDs) as kind basic treatment, followed by tumour necrosis factor (TNF)–blocker if this conventional fails. If clinical picture is dominated peripheral symptoms such arthritis or enthesitis, with sulfasalazine and/or local steroid injection should be tried first before TNF blockers considered.
springer.com
sci-hub.st 参考文章(166)
L. Kanz, T. Daikeler, F. Schick, J. Trübenbach, P. L. Pereira, I. Kötter, I. Günaydin, M. Mohren, Magnetic resonance imaging guided corticosteroid injection of the sacroiliac joints in patients with therapy resistant spondyloarthropathy: a pilot study. The Journal of Rheumatology. ,vol. 27, pp. 424- 428 ,(2000)
A Spoorenberg, K de Vlam, H van der Tempel, S van der Linden, H Mielants, M Dougados, E de Klerk, D van der Heijde, Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. The Journal of Rheumatology. ,vol. 26, pp. 980- 984 ,(1999)
M Figueroa, A Raber, E Batlle-Gualda, J Ivorra, The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group. The Journal of Rheumatology. ,vol. 23, pp. 1200- 1206 ,(1996)
H Whitelock, A Calin, S L Garrett, J Porter, L G Kennedy, S D Jones, A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) The Journal of Rheumatology. ,vol. 22, pp. 1609- ,(1995)
Muhammad Asim Khan, A double blind comparison of diclofenac and indomethacin in the treatment of ankylosing spondylitis. The Journal of Rheumatology. ,vol. 14, pp. 118- 123 ,(1987)
M Bollow, U Eggens, A Distler, J Sieper, J Braun, H J Häberle, F Seyrekbasan, A Mertz, Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis : Clinical outcome and followup by dynamic magnetic resonance imaging The Journal of Rheumatology. ,vol. 23, pp. 659- 664 ,(1996)
A Helewa, C Goldsmith, B Stokes, G Kraag, J Groh, The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--a randomized controlled trial. The Journal of Rheumatology. ,vol. 17, pp. 228- 233 ,(1990)
H Whitelock, P Mallorie, A Calin, S Garrett, L G Kennedy, J O'Hea, T Jenkinson, A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. The Journal of Rheumatology. ,vol. 21, pp. 2281- 2285 ,(1994)
C J Menkes, B Amor, S Pattin, M Dougados, V Listrat, F Blotman, C Benhamou, J B Paolaggi, H Roux, B Duquesnoy, Are classification criteria for spondylarthropathy useful as diagnostic criteria Revue du rhumatisme (English ed.). ,vol. 62, pp. 10- 15 ,(1995)
Junmin Chen, Chao Liu, Sulfasalazine for ankylosing spondylitis Cochrane Database of Systematic Reviews. ,vol. 11, ,(2014) , 10.1002/14651858.CD004800.PUB2